https://www.selleckchem.com/pr....oducts/i-brd9-gsk602
The SVP instrument accurately defines the diverse patient populations with PeVD, an important step in improving clinical decision making, developing disease-specific outcome measures and identifying homogenous patient populations for clinical trials. We have summarized the incidence, anticoagulation panels, laboratory characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with coronavirus disease 2019 (COVID-19). After systematically searching PubMed, Embase, the Cochrane Library, MedRxiv, and BioR
Like
Comment
Share
